S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
BATS:IEIH

iShares Evolved U.S. Innovative Healthcare ETF (IEIH) Price, Holdings, & News

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free IEIH Stock Alerts
$34.13
0.00 (0.00%)
(As of 08/25/2022)
Compare
Today's Range
$34.13
▼
$34.13
50-Day Range
$34.13
▼
$34.13
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
Assets Under Management
$35.83 million
Dividend Yield
N/A
Net Expense Ratio
0.18%
Stock Analysis
Stock Analysis

IEIH Stock Price History

IEIH ETF News Headlines

December 6, 2023 | health.usnews.com
Optimum Platinum Plan (HMO)
July 20, 2023 | seekingalpha.com
ITB iShares U.S. Home Construction ETF
April 19, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
May 17, 2023 | fool.com
iShares U.s. ETF Trust - BlackRock Short Maturity Bond ETF (NYSEMKT: NEAR)
March 24, 2022 | seekingalpha.com
iShares Evolved U.S. Innovative Healthcare ETF declares quarterly distribution of $0.1487
January 11, 2022 | finance.yahoo.com
Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit
November 23, 2021 | finance.yahoo.com
Will Pfizer ETFs Soar on Positive COVID-19 Vaccine Updates?
October 2, 2021 | msn.com
Take a Look at the Top-Performing Biotech ETFs YTD
April 19, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
July 31, 2021 | finance.yahoo.com
iShares Evolved U.S. Innovative Healthcare ETF (IEIH)
See More Headlines
Receive IEIH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Evolved U.S. Innovative Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares Evolved U.S. Innovative Healthcare ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:IEIH
Inception Date
3/21/2018
Fund Manager
Travis Cooke, Jeff Shen
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$35.83 million
Average Daily Volume
$3,485.10
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Latour Trading

Miscellaneous

Outstanding Shares
N/A
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Ad Altimetry
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Click for my No. 1 investment, all free of charge, click here. 

iShares Evolved U.S. Innovative Healthcare ETF Expenses

TypeIEIHHealth Care ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.18%0.56%0.54%0.56%0.51%
Other Expenses0.00%0.40%0.54%0.51%0.58%
Total Expense0.18%0.72%0.70%0.68%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.34%-0.57%
Net Expense0.18%0.60%0.60%0.63%0.58%

iShares Evolved U.S. Innovative Healthcare ETF (IEIH) Exposure

IEIH Geographic Exposure

IEIH Currency Exposure

Full Holdings Details

IEIH ETF - Frequently Asked Questions

How have IEIH shares performed in 2024?

iShares Evolved U.S. Innovative Healthcare ETF's stock was trading at $34.1348 at the beginning of 2024. Since then, IEIH shares have increased by 0.0% and is now trading at $34.1348.
View the best growth stocks for 2024 here.

What does IEIH invest in?

iShares Evolved U.S. Innovative Healthcare ETF is a equity fund issued by iShares. IEIH focuses on health care investments. The fund's investments total to approximately $35.83 million assets under management.

What is the management fee for iShares Evolved U.S. Innovative Healthcare ETF?

iShares Evolved U.S. Innovative Healthcare ETF's management fee is 0.18% and has no other recorded expenses or fee waivers. The net expense ratio for IEIH is 0.18%.

What other stocks do shareholders of iShares Evolved U.S. Innovative Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Evolved U.S. Innovative Healthcare ETF investors own include Intel (INTC), Pfizer (PFE), CrowdStrike (CRWD), DocuSign (DOCU), Inovio Pharmaceuticals (INO), Hello Group (MOMO), ONEOK (OKE), Valero Energy (VLO) and Corbus Pharmaceuticals (CRBP).

How do I buy shares of iShares Evolved U.S. Innovative Healthcare ETF?

Shares of IEIH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (BATS:IEIH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes